Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Mesnard

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2021
AIM2 Suppresses Inflammation and Epithelial Cell Proliferation during GlomerulonephritisHyunjae Chung, Takanori Komada, Arthur Lau, et al.
Journal of the American Society of Nephrology : JASN|May 23, 2015
Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GNCarole Henique, Guillaume Bollee, Olivia Lenoir, et al.
Nephron Extra|April 4, 2012
Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patientsPierre-Antoine Michel, Karine Dahan, Pierre-Yves Ancel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 14, 2023
Additional Benefits of Rituximab and Plasma Exchange on Top of Standard Induction Therapy in Kidney Transplant Recipients With a Negative CDC Crossmatch but High Preformed Donor Specific Antibody TiterInna Mohamadou, Marie Matignon, Stéphanie Malard, et al.
Orphanet Journal of Rare Diseases|May 2, 2013
Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter studyThomas Stehlé, Dominique Joly, Philippe Vanhille, et al.
Therapie|December 22, 2024
Céline Verstuyft, Dominique Dewolf, Olivier Blin, et al.
Therapie|January 9, 2025
How to facilitate the wider use of pharmacogenetic tests?Céline Verstuyft, Dominique Dewolf, Olivier Blin, et al.
Orphanet Journal of Rare Diseases|July 4, 2026
Increased awareness around an ultra-rare disease can improve diagnosis delays: the French example in primary hyperoxaluriasLara Cabezas, Aurélie De Mul, Laurence Derain, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2020
Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trialJulien Coussement, Nassim Kamar, Marie Matignon, et al.
Kidney International|January 24, 2017
Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritisYosu Luque, Dominique Cathelin, Sophie Vandermeersch, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2021
AIM2 Suppresses Inflammation and Epithelial Cell Proliferation during GlomerulonephritisHyunjae Chung, Takanori Komada, Arthur Lau, et al.
Journal of the American Society of Nephrology : JASN|May 23, 2015
Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GNCarole Henique, Guillaume Bollee, Olivia Lenoir, et al.
Nephron Extra|April 4, 2012
Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patientsPierre-Antoine Michel, Karine Dahan, Pierre-Yves Ancel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 14, 2023
Additional Benefits of Rituximab and Plasma Exchange on Top of Standard Induction Therapy in Kidney Transplant Recipients With a Negative CDC Crossmatch but High Preformed Donor Specific Antibody TiterInna Mohamadou, Marie Matignon, Stéphanie Malard, et al.
Orphanet Journal of Rare Diseases|May 2, 2013
Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter studyThomas Stehlé, Dominique Joly, Philippe Vanhille, et al.
Therapie|December 22, 2024
Céline Verstuyft, Dominique Dewolf, Olivier Blin, et al.
Therapie|January 9, 2025
How to facilitate the wider use of pharmacogenetic tests?Céline Verstuyft, Dominique Dewolf, Olivier Blin, et al.
Orphanet Journal of Rare Diseases|July 4, 2026
Increased awareness around an ultra-rare disease can improve diagnosis delays: the French example in primary hyperoxaluriasLara Cabezas, Aurélie De Mul, Laurence Derain, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2020
Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trialJulien Coussement, Nassim Kamar, Marie Matignon, et al.
Kidney International|January 24, 2017
Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritisYosu Luque, Dominique Cathelin, Sophie Vandermeersch, et al.
Pageof 14